SouthState Corp Buys 782 Shares of GE HealthCare Technologies Inc. $GEHC

SouthState Corp boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 46.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,449 shares of the company’s stock after acquiring an additional 782 shares during the quarter. SouthState Corp’s holdings in GE HealthCare Technologies were worth $181,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GEHC. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies in the 1st quarter worth about $25,000. Bogart Wealth LLC boosted its position in GE HealthCare Technologies by 260.0% in the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after buying an additional 247 shares in the last quarter. Gladwyn Financial Advisors Inc. bought a new stake in GE HealthCare Technologies during the second quarter worth about $34,000. Game Plan Financial Advisors LLC grew its stake in GE HealthCare Technologies by 295.3% during the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after buying an additional 375 shares during the last quarter. Finally, Zions Bancorporation National Association UT acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth approximately $42,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Down 1.5%

Shares of GEHC opened at $73.05 on Friday. The stock’s fifty day simple moving average is $75.12 and its 200-day simple moving average is $73.42. The firm has a market capitalization of $33.28 billion, a PE ratio of 15.09, a price-to-earnings-growth ratio of 2.79 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. During the same period in the previous year, the business posted $1.14 EPS. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

Wall Street Analyst Weigh In

GEHC has been the topic of several recent analyst reports. BTIG Research set a $87.00 target price on GE HealthCare Technologies in a report on Wednesday, October 29th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Morgan Stanley lifted their price target on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Finally, Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $93.00 to $83.00 in a research report on Tuesday, October 7th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.